News & Media

Latest Updates

Stay up to date on Block Biosciences' research milestones, media coverage, and appearances in the Canadian life sciences community.

What's New

Workomics Article Feature

Reducing the risk of cancer metastasis to the brain

April 24, 2026

Workomics Article Feature

April 24, 2026

Block Biosciences Wins Audience Choice Award at FACIT's Falcons' Fortunes

April 17, 2026

Sai Life Sciences Biotech Pitch Day Showcases Global Innovation

April 7, 2026

Our Journey

OBIO® Supports Women-led Innovation with Investment in Block Biosciences

Intercepting cancer before it spreads: Block Biosciences lands $100,000 OBIO WiHI investment.

March 31, 2026

OBIO® Supports Women-led Innovation with Investment in Block Biosciences

Intercepting cancer before it spreads: Block Biosciences lands $100,000 OBIO WiHI investment.

March 31, 2026

Taking the Stage: Block Biosciences at the OBIO 2026 Summit

Block Biosciences Shares Vision for Brain Metastasis Prevention at OBIO Summit

February 3, 2026

Taking the Stage: Block Biosciences at the OBIO 2026 Summit

Block Biosciences Shares Vision for Brain Metastasis Prevention at OBIO Summit

February 3, 2026

McMaster Seed Fund invests in three new life sciences startups

Block Biosciences, Tessella Biosciences Inc. and NodeAI have each received $245,000 in the fifth round of MSF investments, announced at Mentorship Day this month

October 9, 2025

McMaster Seed Fund invests in three new life sciences startups

Block Biosciences, Tessella Biosciences Inc. and NodeAI have each received $245,000 in the fifth round of MSF investments, announced at Mentorship Day this month

October 9, 2025

Block Biosciences: McMaster startup aims to prevent cancer from spreading to the brain

A McMaster startup is developing a treatment to prevent cancer from spreading to the brain, an innovation that could revolutionize the future of cancer care.

October 9, 2025

Block Biosciences: McMaster startup aims to prevent cancer from spreading to the brain

A McMaster startup is developing a treatment to prevent cancer from spreading to the brain, an innovation that could revolutionize the future of cancer care.

October 9, 2025

De novo GTP synthesis is a metabolic vulnerability for the interception of brain metastases

Phenotype-guided study reveals therapeutic target that may slow brain metastasis progression

October 15, 2024

De novo GTP synthesis is a metabolic vulnerability for the interception of brain metastases

Phenotype-guided study reveals therapeutic target that may slow brain metastasis progression

October 15, 2024

McMaster chemists and neurobiologists team up to tackle cancer that spreads to the brain

The research team intends to spin-out a new start-up company that will focus on translating this research into a first-in-class precision medicine against brain metastasis.

October 2, 2024

McMaster chemists and neurobiologists team up to tackle cancer that spreads to the brain

The research team intends to spin-out a new start-up company that will focus on translating this research into a first-in-class precision medicine against brain metastasis.

October 2, 2024

McMaster and adMare partner to bring life sciences innovations to the market

With adMare’s support, critical experiments and studies will be performed to develop a targeted therapy and approach that could prevent the formation of metastases in patients with brain cancer.

November 3, 2022

McMaster and adMare partner to bring life sciences innovations to the market

With adMare’s support, critical experiments and studies will be performed to develop a targeted therapy and approach that could prevent the formation of metastases in patients with brain cancer.

November 3, 2022